FEXOFENADINE HCL

FEXOFENADINE HCL was reported 3352 times

FEXOFENADINE HCL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 METHYLENETETRAHYDROFOLATE REDUCTASE GENE MUTATION 3 0.0625
1 CREATINE PHOSPHOKINASE DECREASED 2 0.0211
2 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 4 0.0169
3 VASCULAR ACCESS SITE COMPLICATION 3 0.0119
4 AEROPHAGIA 2 0.0115
5 MUCOSAL DISCOLOURATION 7 0.0109
6 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE 2 0.0080
7 RETROGRADE AMNESIA 4 0.0079
8 CHONDROMALACIA 2 0.0070
9 GALLBLADDER CHOLESTEROLOSIS 3 0.0066
10 PRODUCT COMMINGLING 6 0.0056
11 LIP DISCOLOURATION 7 0.0055
12 HAEMANGIOMA OF SKIN 2 0.0046
13 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE II 2 0.0043
14 PCO2 DECREASED 4 0.0041
15 LENTIGO 2 0.0040
16 INFECTIOUS COLITIS 2 0.0038
17 POST-TRAUMATIC NECK SYNDROME 3 0.0037
18 EXTRA DOSE ADMINISTERED 149 0.0037
19 SEBORRHOEIC KERATOSIS 5 0.0034
20 CALCIUM DEFICIENCY 4 0.0031
21 ANION GAP INCREASED 4 0.0030
22 INFUSION SITE URTICARIA 2 0.0030
23 PRE-EXISTING CONDITION IMPROVED 18 0.0029
24 CUSHING'S SYNDROME 2 0.0029
25 BORDERLINE PERSONALITY DISORDER 2 0.0028
26 CONJUNCTIVITIS ALLERGIC 4 0.0027
27 ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED 2 0.0025
28 LYMPHOCYTE STIMULATION TEST POSITIVE 2 0.0025
29 ADRENAL MASS 2 0.0024
30 ALLERGY TO CHEMICALS 3 0.0024
31 JC VIRUS TEST POSITIVE 2 0.0024
32 COLONIC ABSCESS 2 0.0023
33 BLOOD PH DECREASED 4 0.0023
34 PRODUCT QUALITY ISSUE 317 0.0023
35 FOREIGN BODY IN RESPIRATORY TRACT 3 0.0023
36 PRODUCT LOT NUMBER ISSUE 5 0.0023
37 THERAPEUTIC PROCEDURE 3 0.0021
38 OBSTRUCTIVE SLEEP APNOEA SYNDROME 3 0.0021
39 INFUSION SITE INDURATION 3 0.0020
40 REBOUND ACID HYPERSECRETION 6 0.0020
41 TINEA PEDIS 3 0.0019
42 HAEMORRHAGIC DISORDER 2 0.0018
43 ACUTE SINUSITIS 3 0.0017
44 FULL BLOOD COUNT INCREASED 2 0.0017
45 DYSFUNCTIONAL UTERINE BLEEDING 2 0.0016
46 BLOOD IMMUNOGLOBULIN G INCREASED 2 0.0016
47 TONGUE DISCOLOURATION 7 0.0016
48 INTRADUCTAL PROLIFERATIVE BREAST LESION 2 0.0016
49 BLOOD BICARBONATE DECREASED 3 0.0016
50 INFUSION SITE IRRITATION 2 0.0016
51 EXPIRED PRODUCT ADMINISTERED 51 0.0015
52 FOREIGN BODY 6 0.0015
53 SPINAL COLUMN STENOSIS 7 0.0015
54 BODY MASS INDEX INCREASED 2 0.0015
55 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 6 0.0014
56 MAST CELL ACTIVATION SYNDROME 2 0.0014
57 SEASONAL ALLERGY 20 0.0014
58 CATAPLEXY 2 0.0014
59 GLUTEN SENSITIVITY 2 0.0014
60 SHOULDER OPERATION 6 0.0014
61 APRAXIA 2 0.0013
62 URINE ANALYSIS ABNORMAL 4 0.0013
63 HYPOAESTHESIA FACIAL 2 0.0013
64 GASTRIC POLYPS 3 0.0013
65 ADHESION 2 0.0013
66 NEPHROGENIC ANAEMIA 6 0.0013
67 GASTROSTOMY 2 0.0013
68 CUSHINGOID 4 0.0012
69 STARING 3 0.0012
70 DERMATITIS CONTACT 14 0.0012
71 OEDEMA MOUTH 4 0.0012
72 INFUSION SITE HAEMORRHAGE 4 0.0012
73 COLONIC POLYP 2 0.0012
74 MITRAL VALVE PROLAPSE 2 0.0012
75 DEMENTIA ALZHEIMER'S TYPE 2 0.0012
76 HYPERPARATHYROIDISM SECONDARY 3 0.0012
77 PARKINSON'S DISEASE 3 0.0012
78 BILIARY DYSKINESIA 2 0.0012
79 CHOREA 2 0.0012
80 LIPOMA 3 0.0012
81 ACTINIC KERATOSIS 3 0.0012
82 HERNIA REPAIR 3 0.0012
83 HYPOPITUITARISM 2 0.0011
84 RADICULOPATHY 3 0.0011
85 RHINITIS ALLERGIC 5 0.0011
86 AORTIC VALVE STENOSIS 2 0.0011
87 PRODUCT SIZE ISSUE 6 0.0011
88 SHOULDER ARTHROPLASTY 3 0.0011
89 ORAL FUNGAL INFECTION 3 0.0011
90 ESSENTIAL HYPERTENSION 2 0.0011
91 DIABETIC COMA 3 0.0011
92 BLADDER SPASM 2 0.0011
93 PANCREATIC CARCINOMA METASTATIC 3 0.0011
94 SLEEP APNOEA SYNDROME 20 0.0010
95 INTENTIONAL MISUSE 2 0.0010
96 KIDNEY TRANSPLANT REJECTION 5 0.0010
97 FAECAL INCONTINENCE 5 0.0010
98 PRODUCT ADMINISTRATION ERROR 21 0.0010
99 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
100 MULTIPLE ALLERGIES 8 0.0010
101 HYPOGLYCAEMIC UNCONSCIOUSNESS 2 0.0010
102 MULTIPLE DRUG OVERDOSE 5 0.0010
103 CANDIDIASIS 4 0.0010
104 EYELID PAIN 2 0.0010
105 ACCIDENTAL OVERDOSE 36 0.0010
106 CHANGE OF BOWEL HABIT 2 0.0010
107 DIASTOLIC DYSFUNCTION 3 0.0010
108 RESPIRATORY RATE DECREASED 3 0.0010
109 LUNG ABSCESS 2 0.0010
110 DILATATION VENTRICULAR 2 0.0010
111 INFUSION SITE PRURITUS 3 0.0009
112 INFUSION SITE ERYTHEMA 8 0.0009
113 EYE CONTUSION 2 0.0009
114 POLYMYALGIA RHEUMATICA 3 0.0009
115 INFUSION SITE BRUISING 2 0.0009
116 PHARYNGEAL SWELLING 9 0.0009
117 MELANOCYTIC NAEVUS 4 0.0009
118 SUSPECTED COVID-19 3 0.0009
119 MIDDLE EAR EFFUSION 2 0.0009
120 CATHETERISATION CARDIAC 4 0.0009
121 LARGE INTESTINAL OBSTRUCTION 2 0.0009
122 INFECTIOUS MONONUCLEOSIS 2 0.0009
123 COMPUTERISED TOMOGRAM ABNORMAL 2 0.0009
124 EAR DISORDER 4 0.0009
125 INFUSION SITE INFECTION 2 0.0009
126 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
127 INGROWING NAIL 2 0.0008
128 VIRAL UPPER RESPIRATORY TRACT INFECTION 4 0.0008
129 PRODUCT COMPLAINT 21 0.0008
130 BLOOD PHOSPHORUS DECREASED 3 0.0008
131 VITAMIN D DEFICIENCY 8 0.0008
132 DERMAL CYST 2 0.0008
133 ALCOHOL USE 3 0.0008
134 DIABETIC NEUROPATHY 4 0.0008
135 DEVICE INFUSION ISSUE 2 0.0008
136 INFUSION SITE SWELLING 5 0.0008
137 PARANASAL SINUS DISCOMFORT 3 0.0008
138 EXCORIATION 2 0.0008
139 PATHOLOGICAL FRACTURE 4 0.0008
140 PARANASAL SINUS HYPERSECRETION 3 0.0008
141 WRONG DRUG ADMINISTERED 7 0.0008
142 INITIAL INSOMNIA 8 0.0008
143 INFUSION SITE PAIN 10 0.0008
144 BLOOD CHLORIDE DECREASED 2 0.0008
145 PELVIC FRACTURE 6 0.0008
146 WOUND SECRETION 3 0.0008
147 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
148 EXFOLIATIVE RASH 2 0.0008
149 SNEEZING 17 0.0008
150 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
151 CHOLECYSTITIS CHRONIC 5 0.0007
152 INTERNATIONAL NORMALISED RATIO DECREASED 3 0.0007
153 CHONDROPATHY 2 0.0007
154 PERIPHERAL VENOUS DISEASE 3 0.0007
155 ANKLE FRACTURE 11 0.0007
156 THERMAL BURN 5 0.0007
157 JOINT LOCK 2 0.0007
158 HEART VALVE INCOMPETENCE 2 0.0007
159 BLOOD MAGNESIUM DECREASED 6 0.0007
160 FIBULA FRACTURE 2 0.0007
161 HYSTERECTOMY 6 0.0007
162 ADENOVIRUS INFECTION 2 0.0007
163 LUMBAR SPINAL STENOSIS 2 0.0007
164 CHRONIC KIDNEY DISEASE 52 0.0007
165 ONYCHOMYCOSIS 3 0.0007
166 SPINAL OSTEOARTHRITIS 6 0.0007
167 FEELING JITTERY 13 0.0007
168 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
169 CYTOMEGALOVIRUS VIRAEMIA 3 0.0007
170 NO ADVERSE EVENT 122 0.0007
171 FACIAL PAIN 6 0.0007
172 CREPITATIONS 2 0.0007
173 ODYNOPHAGIA 4 0.0007
174 ATYPICAL PNEUMONIA 2 0.0007
175 TYPE 1 DIABETES MELLITUS 4 0.0007
176 NOCTURIA 8 0.0007
177 END STAGE RENAL DISEASE 12 0.0007
178 DIABETIC FOOT 2 0.0007
179 DYSAESTHESIA 2 0.0007
180 CHEST X-RAY ABNORMAL 2 0.0007
181 RENAL FAILURE CHRONIC 5 0.0006
182 IRON DEFICIENCY ANAEMIA 6 0.0006
183 BRAIN DEATH 2 0.0006
184 RENAL FUNCTION TEST ABNORMAL 3 0.0006
185 NASAL DRYNESS 4 0.0006
186 DRUG EFFECT INCREASED 2 0.0006
187 NASAL DISCOMFORT 5 0.0006
188 LIMB OPERATION 3 0.0006
189 ROTATOR CUFF SYNDROME 8 0.0006
190 HYPERCHOLESTEROLAEMIA 6 0.0006
191 STENT PLACEMENT 5 0.0006
192 RASH GENERALISED 16 0.0006
193 HEPATITIS ACUTE 4 0.0006
194 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
195 BREAST ENLARGEMENT 2 0.0006
196 DEAFNESS NEUROSENSORY 2 0.0006
197 SPINAL COMPRESSION FRACTURE 5 0.0006
198 LYME DISEASE 2 0.0006
199 VEIN DISORDER 3 0.0006
200 SKIN MASS 4 0.0006
201 DRUG TOLERANCE 3 0.0006
202 METASTASES TO LYMPH NODES 4 0.0006
203 CLOSTRIDIAL INFECTION 2 0.0006
204 INTERNATIONAL NORMALISED RATIO ABNORMAL 2 0.0006
205 APLASIA PURE RED CELL 2 0.0006
206 FOOT FRACTURE 11 0.0006
207 VENTRICULAR EXTRASYSTOLES 6 0.0006
208 HYPOPNOEA 2 0.0006
209 HANGOVER 2 0.0006
210 LOGORRHOEA 2 0.0006
211 JOINT DISLOCATION 6 0.0006
212 FULL BLOOD COUNT ABNORMAL 6 0.0006
213 BLOOD POTASSIUM DECREASED 17 0.0006
214 LUNG TRANSPLANT 2 0.0006
215 GLOSSITIS 2 0.0006
216 DIVERTICULUM 4 0.0006
217 LACRIMATION INCREASED 17 0.0006
218 GASTROINTESTINAL INFECTION 5 0.0006
219 PHARYNGITIS STREPTOCOCCAL 6 0.0006
220 GASTROENTERITIS VIRAL 10 0.0006
221 MONOCYTE COUNT INCREASED 2 0.0006
222 TIC 3 0.0005
223 MAJOR DEPRESSION 4 0.0005
224 FEELING DRUNK 4 0.0005
225 BONE DENSITY ABNORMAL 2 0.0005
226 SINUSITIS 54 0.0005
227 CHOLECYSTECTOMY 6 0.0005
228 INSURANCE ISSUE 8 0.0005
229 LIPASE INCREASED 4 0.0005
230 LOWER LIMB FRACTURE 10 0.0005
231 SINUS CONGESTION 7 0.0005
232 RETCHING 11 0.0005
233 RENAL TUBULAR NECROSIS 5 0.0005
234 COELIAC DISEASE 5 0.0005
235 BRADYKINESIA 3 0.0005
236 IDIOPATHIC PULMONARY FIBROSIS 2 0.0005
237 SINUS HEADACHE 3 0.0005
238 SINUS DISORDER 10 0.0005
239 CARPAL TUNNEL SYNDROME 7 0.0005
240 ENURESIS 2 0.0005
241 DRY THROAT 5 0.0005
242 GOITRE 2 0.0005
243 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
244 EXTRAVASATION 2 0.0005
245 PHOTOSENSITIVITY REACTION 8 0.0005
246 VIRAL INFECTION 16 0.0005
247 TUBULOINTERSTITIAL NEPHRITIS 9 0.0005
248 CONGESTIVE CARDIOMYOPATHY 2 0.0005
249 PETECHIAE 5 0.0005
250 ASTHMA 54 0.0005
251 MULTIPLE INJURIES 3 0.0005
252 TYPE 2 DIABETES MELLITUS 16 0.0005
253 SCRATCH 5 0.0005
254 RENAL FAILURE ACUTE 20 0.0005
255 FOREIGN BODY SENSATION IN EYES 3 0.0005
256 WHITE BLOOD CELL COUNT ABNORMAL 3 0.0005
257 AORTIC VALVE INCOMPETENCE 2 0.0005
258 ABSCESS LIMB 2 0.0005
259 BREAST PAIN 5 0.0005
260 GALACTORRHOEA 3 0.0005
261 POOR QUALITY SLEEP 10 0.0005
262 CARDIAC FLUTTER 3 0.0005
263 INCOHERENT 3 0.0005
264 EAR PAIN 9 0.0005
265 ECONOMIC PROBLEM 7 0.0005
266 OSTEOPENIA 7 0.0005
267 CHAPPED LIPS 2 0.0005
268 MONOPLEGIA 2 0.0005
269 TENDON DISORDER 3 0.0005
270 SKIN LACERATION 5 0.0005
271 BRADYPHRENIA 3 0.0005
272 RASH MACULAR 16 0.0005
273 RESPIRATORY RATE INCREASED 4 0.0005
274 VENTRICULAR FIBRILLATION 5 0.0004
275 TOOTH DISORDER 10 0.0004
276 POST-TRAUMATIC STRESS DISORDER 3 0.0004
277 ANAL INCONTINENCE 4 0.0004
278 PRODUCT USE COMPLAINT 7 0.0004
279 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
280 EYE INFECTION 5 0.0004
281 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 3 0.0004
282 RESTLESS LEGS SYNDROME 8 0.0004
283 MICTURITION URGENCY 5 0.0004
284 OSTEOPOROSIS 18 0.0004
285 ONYCHOCLASIS 3 0.0004
286 ISCHAEMIA 2 0.0004
287 INCREASED TENDENCY TO BRUISE 4 0.0004
288 NIGHT SWEATS 14 0.0004
289 DIVERTICULITIS 12 0.0004
290 BRONCHITIS 32 0.0004
291 ARTHRITIS INFECTIVE 2 0.0004
292 HUNGER 6 0.0004
293 ELECTROLYTE IMBALANCE 5 0.0004
294 EYE SWELLING 16 0.0004
295 ERYTHEMA MULTIFORME 4 0.0004
296 DUODENAL ULCER 3 0.0004
297 SQUAMOUS CELL CARCINOMA 4 0.0004
298 BLOOD SODIUM DECREASED 8 0.0004
299 HAND FRACTURE 3 0.0004
300 SINUS TACHYCARDIA 6 0.0004
301 RESPIRATORY TRACT INFECTION 11 0.0004
302 LIMB DISCOMFORT 13 0.0004
303 IRRITABLE BOWEL SYNDROME 9 0.0004
304 CHOLECYSTITIS 5 0.0004
305 ENDOMETRIOSIS 2 0.0004
306 MEDICATION RESIDUE PRESENT 2 0.0004
307 RHINORRHOEA 27 0.0004
308 SOMNOLENCE 84 0.0004
309 TONGUE DISORDER 3 0.0004
310 FINGER DEFORMITY 2 0.0004
311 FAECES SOFT 3 0.0004
312 DIZZINESS POSTURAL 4 0.0004
313 UPPER RESPIRATORY TRACT INFECTION 19 0.0004
314 HORMONE LEVEL ABNORMAL 2 0.0004
315 DRY MOUTH 33 0.0004
316 RASH PRURITIC 22 0.0004
317 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
318 CEREBRAL DISORDER 3 0.0004
319 LIMB INJURY 11 0.0004
320 HYPERVOLAEMIA 2 0.0004
321 HAEMATOCRIT DECREASED 8 0.0004
322 CYST 5 0.0004
323 PULMONARY MASS 6 0.0004
324 ABDOMINAL TENDERNESS 2 0.0004
325 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 21 0.0004
326 THERAPEUTIC RESPONSE UNEXPECTED 18 0.0004
327 HYDRONEPHROSIS 3 0.0004
328 PRODUCTIVE COUGH 19 0.0004
329 CORONARY ARTERY STENOSIS 2 0.0004
330 CHOLELITHIASIS 13 0.0004
331 DYSPHONIA 23 0.0004
332 GALLBLADDER DISORDER 7 0.0004
333 BOWEL MOVEMENT IRREGULARITY 3 0.0004
334 PROCEDURAL COMPLICATION 3 0.0004
335 FUNGAL INFECTION 13 0.0004
336 FOOD ALLERGY 3 0.0004
337 TENDONITIS 6 0.0004
338 CONCUSSION 3 0.0004
339 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
340 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0004
341 APNOEA 3 0.0004
342 NERVOUSNESS 20 0.0004
343 TORSADE DE POINTES 3 0.0004
344 IMMUNE SYSTEM DISORDER 5 0.0004
345 THROAT IRRITATION 17 0.0004
346 OBESITY 6 0.0004
347 GINGIVITIS 2 0.0004
348 GASTRIC ULCER 7 0.0004
349 BIPOLAR DISORDER 4 0.0004
350 PNEUMONITIS 10 0.0004
351 HICCUPS 3 0.0004
352 WOUND INFECTION 4 0.0004
353 VENTRICULAR TACHYCARDIA 6 0.0004
354 MENTAL STATUS CHANGES 10 0.0004
355 NERVE INJURY 4 0.0004
356 INTRACRANIAL PRESSURE INCREASED 2 0.0004
357 CHOKING 7 0.0004
358 BLOOD UREA INCREASED 6 0.0004
359 HAEMODIALYSIS 3 0.0004
360 EYE PRURITUS 12 0.0004
361 ACUTE PULMONARY OEDEMA 2 0.0004
362 FLATULENCE 20 0.0004
363 GRANULOCYTOPENIA 2 0.0004
364 CARDIAC VALVE DISEASE 2 0.0003
365 RED BLOOD CELL COUNT DECREASED 10 0.0003
366 NEOPLASM 4 0.0003
367 EXERCISE TOLERANCE DECREASED 2 0.0003
368 PHARMACEUTICAL PRODUCT COMPLAINT 9 0.0003
369 ARTHRITIS 27 0.0003
370 DRY EYE 17 0.0003
371 IMMUNOSUPPRESSION 3 0.0003
372 GASTROOESOPHAGEAL REFLUX DISEASE 27 0.0003
373 MUSCLE RIGIDITY 4 0.0003
374 HEARING IMPAIRED 2 0.0003
375 NEURALGIA 8 0.0003
376 ABNORMAL BEHAVIOUR 13 0.0003
377 DISORIENTATION 13 0.0003
378 DRUG DISPENSING ERROR 5 0.0003
379 RETINAL DETACHMENT 3 0.0003
380 FEELING HOT 20 0.0003
381 MUSCLE SPASTICITY 4 0.0003
382 CARDIOMEGALY 4 0.0003
383 SPINAL OPERATION 4 0.0003
384 LARYNGEAL OEDEMA 2 0.0003
385 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
386 TENDON RUPTURE 4 0.0003
387 MUSCULOSKELETAL CHEST PAIN 5 0.0003
388 PHARYNGITIS 4 0.0003
389 HEPATIC STEATOSIS 6 0.0003
390 INFUSION SITE EXTRAVASATION 2 0.0003
391 BLISTER 18 0.0003
392 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
393 PNEUMONIA ASPIRATION 8 0.0003
394 FLANK PAIN 3 0.0003
395 BRAIN FOG 5 0.0003
396 PRODUCT DOSE OMISSION IN ERROR 9 0.0003
397 SPUTUM DISCOLOURED 3 0.0003
398 DIABETES MELLITUS 24 0.0003
399 RECALLED PRODUCT ADMINISTERED 3 0.0003
400 COUGH 88 0.0003
401 ENTERITIS 2 0.0003
402 DRUG INEFFECTIVE 411 0.0003
403 INFLAMMATION 16 0.0003
404 HYPERPROLACTINAEMIA 2 0.0003
405 HERPES SIMPLEX 2 0.0003
406 BACK DISORDER 5 0.0003
407 CONSTIPATION 67 0.0003
408 NODULE 4 0.0003
409 BLOOD CREATININE INCREASED 20 0.0003
410 HOT FLUSH 23 0.0003
411 LABORATORY TEST ABNORMAL 9 0.0003
412 KNEE OPERATION 3 0.0003
413 NEUROPATHY PERIPHERAL 29 0.0003
414 HOSPICE CARE 3 0.0003
415 LIGAMENT SPRAIN 3 0.0003
416 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
417 BLADDER DISORDER 3 0.0003
418 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
419 HYPERGLYCAEMIA 11 0.0003
420 OVERDOSE 65 0.0003
421 RESTLESSNESS 11 0.0003
422 INSOMNIA 80 0.0003
423 COAGULOPATHY 5 0.0003
424 BRAIN INJURY 3 0.0003
425 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
426 ABDOMINAL DISCOMFORT 50 0.0003
427 BRONCHIECTASIS 2 0.0003
428 THROAT TIGHTNESS 8 0.0003
429 TASTE DISORDER 6 0.0003
430 EYELID PTOSIS 3 0.0003
431 DEPRESSION 67 0.0003
432 SLUGGISHNESS 3 0.0003
433 BODY TEMPERATURE INCREASED 6 0.0003
434 DRUG TOXICITY 4 0.0003
435 LIVER DISORDER 13 0.0003
436 RASH ERYTHEMATOUS 14 0.0003
437 URTICARIA 49 0.0003
438 EAR DISCOMFORT 3 0.0003
439 FEELING ABNORMAL 70 0.0003
440 DYSPNOEA EXERTIONAL 11 0.0003
441 PRODUCT PREPARATION ERROR 6 0.0003
442 TEMPERATURE INTOLERANCE 3 0.0003
443 JOINT EFFUSION 2 0.0003
444 POOR VENOUS ACCESS 3 0.0003
445 LARGE INTESTINE POLYP 2 0.0003
446 SWOLLEN TONGUE 9 0.0003
447 PULMONARY HYPERTENSION 6 0.0003
448 LARGE INTESTINE PERFORATION 2 0.0003
449 BLOOD PRESSURE INCREASED 44 0.0003
450 FORMICATION 2 0.0003
451 HYPOMAGNESAEMIA 4 0.0003
452 COORDINATION ABNORMAL 4 0.0003
453 WEIGHT FLUCTUATION 3 0.0003
454 EXTRASYSTOLES 2 0.0003
455 DERMATITIS 6 0.0003
456 NECK PAIN 16 0.0003
457 SPEECH DISORDER 15 0.0003
458 RENAL FAILURE 38 0.0003
459 CATARACT 17 0.0003
460 FLUSHING 29 0.0003
461 BURNING SENSATION 20 0.0003
462 SKIN EXFOLIATION 24 0.0003
463 HEAD INJURY 9 0.0003
464 APPLICATION SITE REACTION 2 0.0003
465 HYPOXIA 10 0.0003
466 PANCREATITIS 15 0.0003
467 SUDDEN DEATH 3 0.0003
468 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
469 DIZZINESS 141 0.0003
470 DYSGEUSIA 21 0.0003
471 CYSTITIS 9 0.0003
472 DIABETES MELLITUS INADEQUATE CONTROL 5 0.0003
473 JOINT INJURY 6 0.0003
474 EPISTAXIS 21 0.0003
475 SYNCOPE 28 0.0003
476 HEREDITARY ANGIOEDEMA 3 0.0003
477 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
478 HYPERSOMNIA 8 0.0003
479 GOUT 5 0.0003
480 DECREASED ACTIVITY 3 0.0003
481 UNEVALUABLE EVENT 21 0.0003
482 ANOSMIA 4 0.0003
483 BACK INJURY 3 0.0003
484 INJECTION SITE HAEMATOMA 4 0.0003
485 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
486 DYSSTASIA 8 0.0003
487 MUSCLE SPASMS 50 0.0003
488 NASAL CONGESTION 16 0.0003
489 TOOTH FRACTURE 3 0.0003
490 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
491 BLOOD GLUCOSE DECREASED 13 0.0003
492 URINARY INCONTINENCE 8 0.0003
493 SKIN HAEMORRHAGE 4 0.0003
494 WHEEZING 16 0.0003
495 URINARY TRACT INFECTION 46 0.0003
496 RENAL INJURY 8 0.0003
497 MIDDLE INSOMNIA 5 0.0003
498 DEAFNESS 7 0.0003
499 BLOOD CALCIUM DECREASED 3 0.0003
500 CHROMATURIA 6 0.0003
501 MYOCARDIAL ISCHAEMIA 3 0.0003
502 AORTIC ANEURYSM 2 0.0003
503 HAEMATURIA 9 0.0003
504 MULTIPLE SCLEROSIS RELAPSE 18 0.0003
505 GASTRIC DISORDER 9 0.0003
506 INCREASED APPETITE 5 0.0003
507 POST PROCEDURAL COMPLICATION 5 0.0003
508 NIGHTMARE 9 0.0003
509 PERIPHERAL SWELLING 40 0.0003
510 THYROID DISORDER 4 0.0003
511 OSTEOARTHRITIS 11 0.0003
512 CELLULITIS 13 0.0003
513 HAEMORRHOIDS 5 0.0003
514 SURGERY 15 0.0003
515 GASTROINTESTINAL INFLAMMATION 2 0.0003
516 SKIN LESION 7 0.0003
517 SLEEP DISORDER 18 0.0003
518 PRURITUS 98 0.0003
519 AFFECTIVE DISORDER 2 0.0003
520 WEIGHT DECREASED 71 0.0003
521 COVID-19 PNEUMONIA 3 0.0003
522 BLOOD IRON DECREASED 3 0.0003
523 MENTAL DISORDER 11 0.0003
524 ILLNESS 26 0.0003
525 FURUNCLE 2 0.0003
526 BLOOD ALBUMIN DECREASED 2 0.0003
527 RESPIRATORY TRACT CONGESTION 4 0.0003
528 HYPERLIPIDAEMIA 3 0.0003
529 ATRIAL FLUTTER 2 0.0003
530 HYPOTHYROIDISM 8 0.0003
531 DEMENTIA 7 0.0003
532 BLOOD PRESSURE FLUCTUATION 6 0.0002
533 LOSS OF CONSCIOUSNESS 32 0.0002
534 ANXIETY 71 0.0002
535 CONTUSION 24 0.0002
536 MIOSIS 2 0.0002
537 HEPATITIS C 3 0.0002
538 PRODUCT PHYSICAL ISSUE 5 0.0002
539 HYPERSENSITIVITY 46 0.0002
540 WRONG TECHNIQUE IN DRUG USAGE PROCESS 9 0.0002
541 PAIN IN JAW 7 0.0002
542 FALL 82 0.0002
543 DEEP VEIN THROMBOSIS 16 0.0002
544 VERTIGO 15 0.0002
545 SWELLING FACE 16 0.0002
546 ASPARTATE AMINOTRANSFERASE INCREASED 13 0.0002
547 INJECTION SITE URTICARIA 6 0.0002
548 ALANINE AMINOTRANSFERASE INCREASED 15 0.0002
549 DYSPEPSIA 24 0.0002
550 HYPERAESTHESIA 2 0.0002
551 EYE DISORDER 8 0.0002
552 EYE IRRITATION 14 0.0002
553 STAPHYLOCOCCAL INFECTION 8 0.0002
554 TOOTH EXTRACTION 3 0.0002
555 HYPERTENSION 51 0.0002
556 AGEUSIA 6 0.0002
557 EOSINOPHIL COUNT INCREASED 2 0.0002
558 DERMATITIS ALLERGIC 3 0.0002
559 ABDOMINAL PAIN UPPER 49 0.0002
560 TREATMENT NONCOMPLIANCE 13 0.0002
561 MUSCULAR WEAKNESS 27 0.0002
562 HAEMATOCHEZIA 13 0.0002
563 TREMOR 39 0.0002
564 FACIAL PARALYSIS 2 0.0002
565 HEPATITIS 6 0.0002
566 ARTHROPATHY 13 0.0002
567 NASOPHARYNGITIS 43 0.0002
568 DYSPNOEA 132 0.0002
569 CARDIAC OPERATION 2 0.0002
570 ANURIA 2 0.0002
571 SKIN CANCER 5 0.0002
572 SKIN ULCER 6 0.0002
573 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 47 0.0002
574 BALANCE DISORDER 20 0.0002
575 MULTI-ORGAN FAILURE 4 0.0002
576 COMA 11 0.0002
577 WHITE BLOOD CELL COUNT DECREASED 25 0.0002
578 PLATELET COUNT INCREASED 3 0.0002
579 FATIGUE 179 0.0002
580 EOSINOPHILIA 4 0.0002
581 BLOOD CALCIUM INCREASED 2 0.0002
582 INFECTION 33 0.0002
583 PULMONARY CONGESTION 3 0.0002
584 HYPOGLYCAEMIA 11 0.0002
585 CHEST PAIN 42 0.0002
586 SOPOR 3 0.0002
587 LUNG INFILTRATION 2 0.0002
588 LYMPHOCYTE COUNT DECREASED 4 0.0002
589 ANGIOEDEMA 10 0.0002
590 HEAD DISCOMFORT 4 0.0002
591 PRODUCT SUBSTITUTION ISSUE 13 0.0002
592 EAR INFECTION 6 0.0002
593 STEVENS-JOHNSON SYNDROME 5 0.0002
594 HEADACHE 141 0.0002
595 TRANSAMINASES INCREASED 5 0.0002
596 RASH MACULO-PAPULAR 5 0.0002
597 INFLUENZA 25 0.0002
598 HAEMOGLOBIN DECREASED 23 0.0002
599 THIRST 4 0.0002
600 QUALITY OF LIFE DECREASED 3 0.0002
601 ORAL PAIN 5 0.0002
602 PAIN OF SKIN 6 0.0002
603 DRUG EFFECT DECREASED 12 0.0002
604 HEART RATE IRREGULAR 5 0.0002
605 PELVIC PAIN 4 0.0002
606 MOOD ALTERED 6 0.0002
607 MIGRAINE 21 0.0002
608 PANIC ATTACK 8 0.0002
609 CORONARY ARTERY OCCLUSION 3 0.0002
610 CARDIAC ARREST 18 0.0002
611 BRAIN NEOPLASM 2 0.0002
612 RESPIRATORY ARREST 6 0.0002
613 DYSURIA 8 0.0002
614 ABNORMAL DREAMS 6 0.0002
615 MUSCLE TWITCHING 5 0.0002
616 DIARRHOEA 140 0.0002
617 OROPHARYNGEAL PAIN 20 0.0002
618 ORAL DISCOMFORT 3 0.0002
619 RHABDOMYOLYSIS 9 0.0002
620 ACUTE KIDNEY INJURY 33 0.0002
621 SEPSIS 24 0.0002
622 HAEMOPTYSIS 6 0.0002
623 APHONIA 3 0.0002
624 CHEST DISCOMFORT 22 0.0002
625 MASS 3 0.0002
626 BLOOD CHOLESTEROL INCREASED 10 0.0002
627 BACTERIAL INFECTION 4 0.0002
628 DIARRHOEA HAEMORRHAGIC 2 0.0002
629 NAUSEA 169 0.0002
630 OEDEMA PERIPHERAL 26 0.0002
631 PNEUMONIA 69 0.0002
632 ARTERIOSCLEROSIS 2 0.0002
633 ABORTION INDUCED 2 0.0002
634 LYMPHOPENIA 3 0.0002
635 MYALGIA 36 0.0002
636 ARRHYTHMIA 10 0.0002
637 BACK PAIN 49 0.0002
638 OCULAR HYPERAEMIA 10 0.0002
639 DYSPHAGIA 20 0.0002
640 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
641 HYPERHIDROSIS 27 0.0002
642 PARALYSIS 3 0.0002
643 ANGINA PECTORIS 6 0.0002
644 HYPOACUSIS 9 0.0002
645 IMPAIRED QUALITY OF LIFE 3 0.0002
646 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 10 0.0002
647 ATELECTASIS 2 0.0002
648 HYPOKINESIA 3 0.0002
649 RESPIRATORY FAILURE 15 0.0002
650 INTENTIONAL PRODUCT USE ISSUE 18 0.0002
651 WEIGHT INCREASED 46 0.0002
652 AUTOIMMUNE DISORDER 2 0.0002
653 SKIN FISSURES 4 0.0002
654 AGITATION 15 0.0002
655 RASH 89 0.0002
656 KIDNEY INFECTION 4 0.0002
657 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
658 MEMORY IMPAIRMENT 28 0.0002
659 OEDEMA 11 0.0002
660 HEART RATE INCREASED 20 0.0002
661 INABILITY TO AFFORD MEDICATION 2 0.0002
662 BLOOD PRESSURE ABNORMAL 4 0.0002
663 PULMONARY OEDEMA 9 0.0002
664 UPPER LIMB FRACTURE 4 0.0002
665 SPINAL FRACTURE 4 0.0002
666 GAIT DISTURBANCE 38 0.0002
667 FULL BLOOD COUNT DECREASED 4 0.0002
668 EMPHYSEMA 2 0.0002
669 CORONARY ARTERY DISEASE 6 0.0002
670 STOMATITIS 12 0.0002
671 HAEMATEMESIS 5 0.0002
672 MOTOR DYSFUNCTION 2 0.0002
673 NEPHROLITHIASIS 9 0.0002
674 MALAISE 86 0.0002
675 TINNITUS 9 0.0002
676 EYE PAIN 11 0.0002
677 DEHYDRATION 26 0.0002
678 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
679 RIB FRACTURE 4 0.0002
680 LYMPHOMA 3 0.0002
681 CONDITION AGGRAVATED 59 0.0002
682 ANAPHYLACTIC SHOCK 5 0.0002
683 FEMUR FRACTURE 6 0.0002
684 UNRESPONSIVE TO STIMULI 5 0.0002
685 RENAL DISORDER 9 0.0002
686 DELUSION 3 0.0002
687 LUNG INFECTION 3 0.0002
688 COGNITIVE DISORDER 9 0.0002
689 CONVULSION 11 0.0002
690 BASAL CELL CARCINOMA 3 0.0002
691 POLLAKIURIA 8 0.0002
692 MUSCULOSKELETAL PAIN 10 0.0002
693 PAIN IN EXTREMITY 56 0.0002
694 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
695 INJECTION SITE REACTION 13 0.0002
696 SCIATICA 3 0.0002
697 CHILLS 22 0.0002
698 JAUNDICE 5 0.0002
699 CONFUSIONAL STATE 30 0.0002
700 MUSCLE TIGHTNESS 3 0.0002
701 DECREASED APPETITE 43 0.0002
702 BLOOD BILIRUBIN INCREASED 5 0.0002
703 BLOOD POTASSIUM INCREASED 3 0.0002
704 FAECES DISCOLOURED 4 0.0002
705 PARAESTHESIA 29 0.0002
706 ASTHENIA 69 0.0002
707 ASPIRATION 2 0.0002
708 VISION BLURRED 25 0.0002
709 ABDOMINAL DISTENSION 19 0.0002
710 INJECTION SITE NODULE 2 0.0002
711 SWELLING 17 0.0002
712 THERAPEUTIC RESPONSE DECREASED 11 0.0002
713 DRUG LEVEL INCREASED 3 0.0002
714 VOMITING 85 0.0002
715 PLEURAL EFFUSION 11 0.0002
716 FOOT DEFORMITY 2 0.0002
717 URINARY RETENTION 6 0.0002
718 PLASMA CELL MYELOMA 7 0.0002
719 INJECTION SITE PRURITUS 12 0.0002
720 GLOSSODYNIA 4 0.0002
721 OXYGEN SATURATION DECREASED 10 0.0002
722 CANDIDA INFECTION 3 0.0002
723 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
724 HYPONATRAEMIA 10 0.0002
725 FLUID RETENTION 9 0.0002
726 MITRAL VALVE INCOMPETENCE 2 0.0002
727 PYREXIA 61 0.0002
728 HEPATIC ENZYME INCREASED 12 0.0002
729 IMPAIRED DRIVING ABILITY 2 0.0002
730 MUSCULOSKELETAL DISCOMFORT 3 0.0002
731 THROMBOSIS 14 0.0002
732 PARANOIA 3 0.0002
733 GASTRIC HAEMORRHAGE 2 0.0002
734 PERICARDIAL EFFUSION 4 0.0002
735 EYELID OEDEMA 2 0.0002
736 BONE PAIN 10 0.0002
737 METASTASES TO LIVER 3 0.0002
738 LUNG NEOPLASM MALIGNANT 7 0.0002
739 DEPRESSED MOOD 9 0.0002
740 COLD SWEAT 3 0.0002
741 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
742 LYMPHADENOPATHY 6 0.0002
743 DRUG ERUPTION 3 0.0002
744 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
745 BACTERAEMIA 2 0.0002
746 ARTHRALGIA 70 0.0002
747 ANAEMIA 32 0.0002
748 CARDIO-RESPIRATORY ARREST 7 0.0002
749 ROAD TRAFFIC ACCIDENT 7 0.0002
750 RESPIRATORY DISORDER 5 0.0002
751 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
752 PRODUCT DOSE OMISSION ISSUE 49 0.0002
753 LEUKOCYTOSIS 3 0.0002
754 TOOTHACHE 3 0.0002
755 APHASIA 5 0.0002
756 MENTAL IMPAIRMENT 4 0.0002
757 BURSITIS 2 0.0002
758 ADRENAL INSUFFICIENCY 2 0.0002
759 ATRIAL FIBRILLATION 16 0.0002
760 DISCOMFORT 10 0.0002
761 CYTOPENIA 2 0.0002
762 INJECTION SITE EXTRAVASATION 2 0.0002
763 HYPERCALCAEMIA 2 0.0002
764 CARDIAC FAILURE CONGESTIVE 13 0.0002
765 CONJUNCTIVITIS 3 0.0002
766 GENERALISED OEDEMA 2 0.0002
767 ERYTHEMA 33 0.0002
768 HEPATIC CIRRHOSIS 3 0.0002
769 INFLUENZA LIKE ILLNESS 13 0.0002
770 DRUG INTERACTION 25 0.0002
771 PRODUCT USE IN UNAPPROVED INDICATION 39 0.0002
772 DRY SKIN 21 0.0002
773 INTRAOCULAR PRESSURE INCREASED 2 0.0002
774 HYPOPHAGIA 4 0.0002
775 SEROTONIN SYNDROME 3 0.0002
776 COMPLETED SUICIDE 13 0.0002
777 ADVERSE DRUG REACTION 14 0.0002
778 MOVEMENT DISORDER 5 0.0002
779 GASTROINTESTINAL HAEMORRHAGE 13 0.0002
780 HIP FRACTURE 5 0.0002
781 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
782 PRESCRIBED OVERDOSE 3 0.0002
783 ABDOMINAL PAIN 36 0.0002
784 DYSTONIA 3 0.0002
785 HYPOTENSION 31 0.0002
786 HIATUS HERNIA 2 0.0002
787 AMNESIA 10 0.0002
788 ORAL HERPES 3 0.0002
789 PRODUCT DOSE OMISSION 10 0.0002
790 ECZEMA 8 0.0002
791 MENORRHAGIA 3 0.0002
792 SEDATION 4 0.0002
793 JOINT STIFFNESS 4 0.0002
794 ANHEDONIA 4 0.0002
795 BEDRIDDEN 2 0.0002
796 DISEASE PROGRESSION 18 0.0002
797 DERMATITIS ATOPIC 8 0.0002
798 DISABILITY 3 0.0002
799 DYSMENORRHOEA 2 0.0002
800 ADVERSE REACTION 2 0.0002
801 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
802 FEBRILE NEUTROPENIA 10 0.0002
803 BLOOD PRESSURE DECREASED 10 0.0002
804 SKIN DISORDER 5 0.0001
805 EYE HAEMORRHAGE 2 0.0001
806 HAIR TEXTURE ABNORMAL 2 0.0001
807 JOINT SWELLING 18 0.0001
808 FEEDING DISORDER 3 0.0001
809 DYSKINESIA 6 0.0001
810 BONE MARROW FAILURE 3 0.0001
811 PALLOR 4 0.0001
812 HYPOAESTHESIA 22 0.0001
813 PAIN 90 0.0001
814 GINGIVAL BLEEDING 2 0.0001
815 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
816 PSORIASIS 19 0.0001
817 INJECTION SITE ERYTHEMA 18 0.0001
818 DRUG INTOLERANCE 14 0.0001
819 PROCEDURAL PAIN 4 0.0001
820 MEDICATION ERROR 8 0.0001
821 FEELING COLD 4 0.0001
822 WOUND 4 0.0001
823 COVID-19 25 0.0001
824 HEART RATE DECREASED 5 0.0001
825 INJURY 10 0.0001
826 HALLUCINATION, VISUAL 3 0.0001
827 TARDIVE DYSKINESIA 4 0.0001
828 INTENTIONAL DOSE OMISSION 4 0.0001
829 PRURITUS GENERALISED 3 0.0001
830 PANCREATIC CARCINOMA 4 0.0001
831 PRODUCT USE ISSUE 26 0.0001
832 HYPERTHYROIDISM 2 0.0001
833 BLOOD GLUCOSE INCREASED 26 0.0001
834 LIVER FUNCTION TEST ABNORMAL 4 0.0001
835 GASTROENTERITIS 2 0.0001
836 UNDERDOSE 10 0.0001
837 PULMONARY EMBOLISM 13 0.0001
838 PALPITATIONS 16 0.0001
839 MELAENA 3 0.0001
840 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
841 CARDIOMYOPATHY 2 0.0001
842 TACHYCARDIA 12 0.0001
843 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
844 COLON CANCER 2 0.0001
845 IMMUNODEFICIENCY 2 0.0001
846 HEPATIC FUNCTION ABNORMAL 5 0.0001
847 RASH PAPULAR 3 0.0001
848 PANCREATITIS ACUTE 3 0.0001
849 BONE LOSS 2 0.0001
850 DYSARTHRIA 5 0.0001
851 HALLUCINATION 10 0.0001
852 INTESTINAL OBSTRUCTION 5 0.0001
853 ALOPECIA 26 0.0001
854 HIP ARTHROPLASTY 2 0.0001
855 HYPOKALAEMIA 6 0.0001
856 BONE DENSITY DECREASED 4 0.0001
857 CYANOSIS 2 0.0001
858 ANAPHYLACTIC REACTION 7 0.0001
859 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9 0.0001
860 INTENTIONAL PRODUCT MISUSE 11 0.0001
861 MUSCULOSKELETAL STIFFNESS 11 0.0001
862 PANCYTOPENIA 7 0.0001
863 DIABETIC KETOACIDOSIS 3 0.0001
864 LOCALISED INFECTION 3 0.0001
865 INTERSTITIAL LUNG DISEASE 6 0.0001
866 FIBROMYALGIA 3 0.0001
867 RHEUMATOID ARTHRITIS 14 0.0001
868 CEREBRAL INFARCTION 3 0.0001
869 PLATELET COUNT DECREASED 13 0.0001
870 LETHARGY 7 0.0001
871 MANIA 2 0.0001
872 DRUG DOSE OMISSION 20 0.0001
873 SUICIDAL IDEATION 11 0.0001
874 LIP SWELLING 4 0.0001
875 RENAL IMPAIRMENT 10 0.0001
876 FACE OEDEMA 2 0.0001
877 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
878 GASTRIC CANCER 3 0.0001
879 NEUTROPENIA 16 0.0001
880 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
881 RECTAL HAEMORRHAGE 5 0.0001
882 THROMBOCYTOPENIA 13 0.0001
883 HAEMATOMA 3 0.0001
884 SUICIDE ATTEMPT 7 0.0001
885 SEPTIC SHOCK 5 0.0001
886 HYPERKALAEMIA 4 0.0001
887 GASTRITIS 3 0.0001
888 FEAR 3 0.0001
889 DISTURBANCE IN ATTENTION 6 0.0001
890 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 20 0.0001
891 HOSPITALISATION 17 0.0001
892 BONE DISORDER 2 0.0001
893 SKIN DISCOLOURATION 5 0.0001
894 ADVERSE EVENT 10 0.0001
895 INJECTION SITE MASS 4 0.0001
896 AGRANULOCYTOSIS 2 0.0001
897 COLITIS 4 0.0001
898 BLOOD URINE PRESENT 2 0.0001
899 INCORRECT DOSE ADMINISTERED 24 0.0001
900 VISUAL IMPAIRMENT 13 0.0001
901 MULTIPLE SCLEROSIS 5 0.0001
902 HERPES ZOSTER 6 0.0001
903 INJECTION SITE SWELLING 8 0.0001
904 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
905 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
906 ACUTE RESPIRATORY FAILURE 2 0.0001
907 SEIZURE 12 0.0001
908 HERNIA 2 0.0001
909 MYOCARDIAL INFARCTION 18 0.0001
910 ASCITES 3 0.0001
911 ACUTE MYOCARDIAL INFARCTION 3 0.0001
912 PSYCHOTIC DISORDER 3 0.0001
913 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
914 CEREBROVASCULAR ACCIDENT 17 0.0001
915 INJECTION SITE BRUISING 8 0.0001
916 HEPATIC FAILURE 3 0.0001
917 ILL-DEFINED DISORDER 6 0.0001
918 BLINDNESS 4 0.0001
919 THERAPY INTERRUPTED 7 0.0001
920 SKIN BURNING SENSATION 7 0.0001
921 EMOTIONAL DISORDER 3 0.0001
922 CARDIAC DISORDER 9 0.0001
923 DRUG-INDUCED LIVER INJURY 3 0.0001
924 WITHDRAWAL SYNDROME 4 0.0001
925 KNEE ARTHROPLASTY 2 0.0001
926 MOUTH ULCERATION 2 0.0001
927 BRADYCARDIA 5 0.0001
928 IMPAIRED WORK ABILITY 2 0.0001
929 LIVER FUNCTION TEST INCREASED 2 0.0001
930 OSTEONECROSIS 3 0.0001
931 INFUSION RELATED REACTION 6 0.0001
932 NEOPLASM MALIGNANT 6 0.0001
933 GAIT INABILITY 3 0.0001
934 GASTROINTESTINAL DISORDER 8 0.0001
935 THERAPY NON-RESPONDER 4 0.0001
936 ANGER 3 0.0001
937 DRUG EXPOSURE DURING PREGNANCY 3 0.0001
938 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
939 CARDIAC FAILURE 7 0.0001
940 HAEMORRHAGE 9 0.0001
941 EMOTIONAL DISTRESS 10 0.0001
942 DRUG EFFECT INCOMPLETE 3 0.0001
943 C-REACTIVE PROTEIN INCREASED 3 0.0001
944 LUNG DISORDER 4 0.0001
945 ENCEPHALOPATHY 2 0.0001
946 ABASIA 2 0.0001
947 EXTRAPYRAMIDAL DISORDER 2 0.0001
948 LEUKOPENIA 4 0.0001
949 AGGRESSION 4 0.0001
950 ABDOMINAL PAIN LOWER 2 0.0001
951 CARDIOVASCULAR DISORDER 2 0.0001
952 THERAPY CESSATION 4 0.0001
953 DRUG RESISTANCE 2 0.0001
954 DIPLOPIA 2 0.0001
955 APPLICATION SITE ERYTHEMA 2 0.0001
956 BREAST CANCER 7 0.0001
957 INJECTION SITE PAIN 23 0.0001
958 BREAST CANCER FEMALE 2 0.0001
959 ABORTION SPONTANEOUS 3 0.0001
960 MENSTRUATION IRREGULAR 2 0.0001
961 NEUTROPHIL COUNT DECREASED 3 0.0001
962 DEATH 60 0.0001
963 MOBILITY DECREASED 5 0.0001
964 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
965 OFF LABEL USE 59 0.0001
966 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
967 IRRITABILITY 4 0.0001
968 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
969 INJECTION SITE RASH 2 0.0001
970 GYNAECOMASTIA 2 0.0001
971 EXPOSURE DURING PREGNANCY 4 0.0001
972 RENAL CANCER 3 0.0001
973 MOOD SWINGS 2 0.0001
974 INJECTION SITE HAEMORRHAGE 5 0.0001
975 IMPAIRED HEALING 2 0.0001
976 DELIRIUM 2 0.0001
977 DEVICE USE ERROR 2 0.0001
978 DRUG WITHDRAWAL SYNDROME 5 0.0001
979 CEREBRAL HAEMORRHAGE 2 0.0001
980 CRYING 2 0.0001
981 TOXICITY TO VARIOUS AGENTS 9 0.0001
982 INTENTIONAL OVERDOSE 3 0.0000
983 DEVICE LEAKAGE 2 0.0000
984 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
985 DISEASE RECURRENCE 2 0.0000
986 BLADDER CANCER 2 0.0000
987 DEVICE ISSUE 3 0.0000
988 DEVICE DIFFICULT TO USE 2 0.0000
989 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
990 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
991 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
992 DRUG ABUSE 2 0.0000
993 DRUG DEPENDENCE 3 0.0000